Research output per year
Research output per year
Fingerprint
Dive into the research topics where Eric Nuermberger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis
Jeffreys, L. N., Ardrey, A., Hafiz, T. A., Dyer, L. A., Warman, A. J., Mosallam, N., Nixon, G. L., Fisher, N. E., Hong, W. D., Leung, S. C., Aljayyoussi, G., Bibby, J., Almeida, D. V., Converse, P., Fotouhi, N., Berry, N. G., Nuermberger, E. L., Upton, A. M., O'neill, P. M., Ward, S. A., & 1 others, 2023, (Accepted/In press) In: ACS Infectious Diseases.Research output: Contribution to journal › Article › peer-review
Open Access -
Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments
Dide-Agossou, C., Bauman, A. A., Ramey, M. E., Rossmassler, K., Al Mubarak, R., Pauly, S., Voskuil, M. I., Garcia-Cremades, M., Savic, R. M., Nahid, P., Moore, C. M., Tasneen, R., Nuermberger, E. L., Robertson, G. T. & Walter, N. D., Apr 2022, In: Antimicrobial agents and chemotherapy. 66, 4Research output: Contribution to journal › Article › peer-review
Open Access -
CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on b-Lactam Susceptibility
Kurepina, N., Chen, L., Composto, K., Rifat, D., Nuermberger, E. L. & Kreiswirth, B. N., Apr 2022, In: Antimicrobial agents and chemotherapy. 66, 4Research output: Contribution to journal › Article › peer-review
-
Drug Efficacy Testing in the Mouse Footpad Model of Buruli Ulcer
Converse, P., Almeida, D. V. & Nuermberger, E. L., 2022, Methods in Molecular Biology. Humana Press Inc., p. 195-207 13 p. (Methods in Molecular Biology; vol. 2387).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis The COMRADE Randomized, Phase 2A Clinical Trial
the COMRADE Study Team, May 15 2022, In: American journal of respiratory and critical care medicine. 205, 10, p. 1228-1235 8 p.Research output: Contribution to journal › Article › peer-review